よむ、つかう、まなぶ。
「日本人の食事摂取基準（2025年版）」策定検討会報告書 (190 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_44138.html |
| 出典情報 | 「日本人の食事摂取基準（2025年版）」策定検討会報告書（10／11）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
Academies Press, Washington, D.C.; 2001.
133) 骨粗鬆症の予防と治療ガイドライン作成委員会編. 骨粗鬆症の予防と治療ガイドライン 2015 年
版. ライフサイエンス出版; 2015.
134) Hao G, Zhang B, Gu M, et al. Vitamin K intake and the risk of fractures: A meta-analysis. Medicine
(Baltimore). 2017;96(17):e6725.
135) Knapen MHJ, Drummen NE, Smit E, et al. Three-year low-dose menaquinone-7 supplementation helps
decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-2507.
136) Rønn SH, Harsløf T, Pedersen SB, et al. Vitamin K2 (menaquinone-7) prevents age-related deterioration of
trabecular
bone
microarchitecture
at
the
tibia
in
postmenopausal
women.
Eur
J
Endocrinol. 2016;175(6):541-549.
137) Shea MK, Barger K, Booth SL, et al. Vitamin K status, cardiovascular disease, and all-cause mortality: a
participant-level meta-analysis of 3 US cohorts. Am J Clin Nutr. 2020;111(6):1170-1177.
138) Chen HG, Sheng LT, Zhang YB, et al. Association of vitamin K with cardiovascular events and all-cause
mortality: a systematic review and meta-analysis. Eur J Nutr. 2019;58(6):2191-2205.
139) Bellinge JW, Dalgaard F, Murray K, et al. Vitamin K intake and atherosclerotic cardiovascular disease in
the Danish Diet Cancer and Health Study. J Am Heart Assoc. 2021;10(16):e020551.
140) Schurgers LJ, Shearer MJ, Hamulyák K, et al. Effect of vitamin K intake on the stability of oral anticoagulant
treatment: dose-response relationships in healthy subjects. Blood. 2004;104(9):2682-2689.
141) Dofferhoff ASM, Piscaer I, Schurgers LJ, et al. Reduced vitamin K status as a potentially modifiable risk
factor of severe coronavirus disease 2019. Clin Infect Dis. 2021;73(11):e4039-e4046.
180
133) 骨粗鬆症の予防と治療ガイドライン作成委員会編. 骨粗鬆症の予防と治療ガイドライン 2015 年
版. ライフサイエンス出版; 2015.
134) Hao G, Zhang B, Gu M, et al. Vitamin K intake and the risk of fractures: A meta-analysis. Medicine
(Baltimore). 2017;96(17):e6725.
135) Knapen MHJ, Drummen NE, Smit E, et al. Three-year low-dose menaquinone-7 supplementation helps
decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-2507.
136) Rønn SH, Harsløf T, Pedersen SB, et al. Vitamin K2 (menaquinone-7) prevents age-related deterioration of
trabecular
bone
microarchitecture
at
the
tibia
in
postmenopausal
women.
Eur
J
Endocrinol. 2016;175(6):541-549.
137) Shea MK, Barger K, Booth SL, et al. Vitamin K status, cardiovascular disease, and all-cause mortality: a
participant-level meta-analysis of 3 US cohorts. Am J Clin Nutr. 2020;111(6):1170-1177.
138) Chen HG, Sheng LT, Zhang YB, et al. Association of vitamin K with cardiovascular events and all-cause
mortality: a systematic review and meta-analysis. Eur J Nutr. 2019;58(6):2191-2205.
139) Bellinge JW, Dalgaard F, Murray K, et al. Vitamin K intake and atherosclerotic cardiovascular disease in
the Danish Diet Cancer and Health Study. J Am Heart Assoc. 2021;10(16):e020551.
140) Schurgers LJ, Shearer MJ, Hamulyák K, et al. Effect of vitamin K intake on the stability of oral anticoagulant
treatment: dose-response relationships in healthy subjects. Blood. 2004;104(9):2682-2689.
141) Dofferhoff ASM, Piscaer I, Schurgers LJ, et al. Reduced vitamin K status as a potentially modifiable risk
factor of severe coronavirus disease 2019. Clin Infect Dis. 2021;73(11):e4039-e4046.
180